Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
509,481,545
-
Share change
-
+4,227,749
-
Total reported value
-
$52,761,611,830
-
Put/Call ratio
-
56%
-
Price per share
-
$103.57
-
Number of holders
-
1,162
-
Value change
-
+$552,946,630
-
Number of buys
-
537
-
Number of sells
-
464
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q2 2021
As of 30 Jun 2021 Edwards Lifesciences Corp - Common Stock (EW) had 1,162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 509,481,545 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Bank of New York Mellon Corp, Capital International Investors, WELLINGTON MANAGEMENT GROUP LLP, BROWN ADVISORY INC, SANDS CAPITAL MANAGEMENT, LLC, ALLIANCEBERNSTEIN L.P., and JANUS HENDERSON GROUP PLC.
This table shows 1,178 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.